Pallas Capital Advisors LLC Invests $558,000 in The Clorox Company $CLX

Pallas Capital Advisors LLC acquired a new stake in The Clorox Company (NYSE:CLXFree Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 5,845 shares of the company’s stock, valued at approximately $558,000.

Other large investors have also bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Clorox by 4.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock valued at $1,970,000 after purchasing an additional 514 shares in the last quarter. Woodline Partners LP raised its holdings in shares of Clorox by 253.7% in the 1st quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock worth $1,532,000 after purchasing an additional 7,465 shares in the last quarter. Baird Financial Group Inc. raised its holdings in shares of Clorox by 1.7% in the 2nd quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock worth $3,006,000 after purchasing an additional 424 shares in the last quarter. Jump Financial LLC lifted its stake in Clorox by 173.5% during the second quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock valued at $1,500,000 after purchasing an additional 7,924 shares during the last quarter. Finally, Bank of Nova Scotia lifted its stake in Clorox by 26.2% during the second quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock valued at $1,938,000 after purchasing an additional 3,352 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have issued reports on CLX. Weiss Ratings restated a “hold (c-)” rating on shares of Clorox in a research report on Friday, July 10th. Jefferies Financial Group lowered Clorox from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $125.00 to $98.00 in a research note on Tuesday, July 28th. Wells Fargo & Company lifted their target price on Clorox from $95.00 to $102.00 and gave the stock an “equal weight” rating in a report on Tuesday, August 4th. Deutsche Bank Aktiengesellschaft set a $98.00 target price on Clorox in a report on Tuesday, August 4th. Finally, Barclays reiterated an “underweight” rating and issued a $84.00 price target on shares of Clorox in a research report on Tuesday, August 4th. Twelve research analysts have rated the stock with a Hold rating and five have given a Sell rating to the company. According to data from MarketBeat.com, Clorox presently has an average rating of “Reduce” and a consensus target price of $102.40.

Read Our Latest Research Report on CLX

Key Stories Impacting Clorox

Here are the key news stories impacting Clorox this week:

  • Positive Sentiment: Clorox’s dividend remains attractive relative to Church & Dwight’s, offering substantially more current income. However, the company has increased its dividend more cautiously, making the stock more appealing to income-focused investors than to growth-oriented investors. Two Consumer Staples, Two Dividend Strategies
  • Neutral Sentiment: Chief Executive Officer Linda Rendle and CFO Luc Bellet will participate in a fireside chat at the Barclays Global Consumer Staples Conference on September 9. The event could provide updates on demand, margins and the company’s outlook, but no new financial guidance was announced. Clorox to Present at Barclays Global Consumer Staples Conference
  • Negative Sentiment: Zacks Research lowered its Q1 2027 EPS forecast to $1.02 from $1.28 and cut its FY2027 estimate to $5.82 from $6.00. It also reduced estimates for Q1 and Q2 2028 and FY2028, while maintaining a “Strong Sell” rating. These revisions signal concern about near-term earnings momentum and are the clearest fundamental pressure on CLX. Zacks Research Estimate Changes
  • Negative Sentiment: An analyst cited weaker Hidden Valley Ranch dressing sales as consumers become more cautious about buying salad products amid a cyclospora outbreak. Any sustained decline in the brand could weigh on Clorox’s food business and quarterly revenue. Hidden Valley Ranch dressing may be a victim of this summer’s salad scare

Clorox Price Performance

Shares of NYSE:CLX opened at $108.12 on Thursday. The company has a current ratio of 0.66, a quick ratio of 0.38 and a debt-to-equity ratio of 15.80. The Clorox Company has a 1 year low of $84.70 and a 1 year high of $128.90. The business has a fifty day simple moving average of $98.62 and a 200 day simple moving average of $103.16. The firm has a market cap of $13.07 billion, a price-to-earnings ratio of 22.43, a P/E/G ratio of 3.16 and a beta of 0.54.

Clorox (NYSE:CLXGet Free Report) last issued its earnings results on Monday, August 3rd. The company reported $1.66 EPS for the quarter, beating analysts’ consensus estimates of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%.The firm had revenue of $1.95 billion for the quarter, compared to the consensus estimate of $1.91 billion. During the same quarter in the previous year, the company posted $2.87 earnings per share. The business’s quarterly revenue was down 2.0% compared to the same quarter last year. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. As a group, sell-side analysts predict that The Clorox Company will post 5.8 earnings per share for the current fiscal year.

Clorox Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, August 28th. Investors of record on Wednesday, August 12th will be paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 4.6%. The ex-dividend date of this dividend is Wednesday, August 12th. This is a positive change from Clorox’s previous quarterly dividend of $1.24. Clorox’s dividend payout ratio (DPR) is presently 103.73%.

About Clorox

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Read More

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.